17-OH-progesterone (17-OHP) is the most suitable biochemical marker for the diagnosis of Congenital Adrenal Hyperplasia (CAH). CAH has a prevalence of around 1-20 in 10,000 children and is one of the most frequent inborn endocrine disorders. The spectrum of clinical presentations ranges from forms with neonatal symptoms, i.e. salt-wasting and simple virilizing forms, to non-classical forms that might not manifest until adulthood.
Measuring this steroid enables early diagnosis and treatment in patients suffering from CAH.
17-OHP is secreted in abundant excess in affected infants due to 21-hydroxylase deficiency. Female patients with late-onset CAH usually have 17-OHP concentrations above the reference interval for the follicular phase of the menstrual cycle.
The IBL International 17-OH-Progesterone ELISA shows following advantages:
For concrete data please consult the Instruction for Use in the download box on the top right side.
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).
As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
At Tecan, we are driven to improve people’s lives and health.
